Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

4P Pharma and Elsevier Life Sciences Collaborate in “the Hive” to Propel Discovery Forward

Posted on April 15th, 2019 by in The Hive

4P Pharmaceutical is an Elsevier partner and Hive participant who has leveraged solutions to further their early stage drug development process. They’ve made great strides in particular with the Elsevier.

(more…)

Emulating start-up success with purpose-built data tools

Posted on December 12th, 2018 by in Pharma R&D

Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. (more…)

Small Biotechs Progressing Beyond Startup Status

Posted on November 29th, 2018 by in Pharma R&D

When is a startup no longer a startup? Small biotech companies armed with a talented crop of scientists have been springing up all across the pharma landscape for the last several years, establishing buzzing hubs of innovation. Not all of them find their research efforts successful, but many do and then go on to be acquired by larger pharmaceutical firms that have the resources to bring their ideas to fruition. (more…)

Tackling Unmet Needs with a Proprietary Platform

Posted on November 22nd, 2018 by in Pharma R&D

Since our founding back in 2006, LegoChem Biosciences (LCB) has focused on the research and development of anti-biotic, anti-coagulant, anti-fibrosis and Antibody-Drug Conjugate (ADC) therapeutics based on our proprietary platform technology, LegoChemistry™ & Conjuall™. LCB is comprised of researchers who have varied backgrounds and R&D experiences, including the development of Factive, the first US FDA-approved drug developed in Korea. (more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 6